An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-κB/MLKL pathway
Authors:
- 4 May 2024
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 132, 155658
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Alcohol induces hepatocytes necroptosis through the LC3/RIPK1/RIPK3 pathwayFood and Chemical Toxicology, 2023
- Intestinal epithelial β Klotho is a critical protective factor in alcohol-induced intestinal barrier dysfunction and liver injuryEBioMedicine, 2022
- Phosphoproteomics identifies pathways underlying the role of receptor‐interaction protein kinase 3 in alcohol‐associated liver disease and uncovers apoptosis signal‐regulating kinase 1 as a targetHepatology Communications, 2022
- Costunolide protects against alcohol‐induced liver injury by regulating gut microbiota, oxidative stress and attenuating inflammation in vivo and in vitroPhytotherapy Research, 2022
- Molecular mechanisms and therapeutic implications of dihydromyricetin in liver diseaseBiomedicine & Pharmacotherapy, 2021
- Diagnosis and Treatment of Alcohol-Associated Liver DiseaseJAMA, 2021
- Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver diseaseHepatology International, 2021
- Network pharmacology-based identification of the protective mechanisms of taraxasterol in experimental colitisInternational Immunopharmacology, 2019
- Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseasesPhytotherapy Research, 2018
- Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injuryHepatology, 2012